Worldwide Chronic Disease Management Industry Insights, 2018-2024: Emphasis on Advance Needle-Free Drug Delivery Technologies, Diagnostic Methods, and Smart Device Technologies

News provided by

Dec 06, 2019, 10:15 ET

DUBLIN, Dec. 6, 2019 /PRNewswire/ -- The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies.

Report Scope

Brief outline of the global markets and therapeutic device technologies for chronic disease management
Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
Key insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
Data corresponding to global chronic disease management markets by disease type that includes various chronic diseases, therapeutic drugs, treatment adherence devices & systems, drug delivery technologies, and treatment & management providers
Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
Detailed company profiles and competitive landscape of major market players, including Roche, AbbVie, Johnson & Johnson, Bristol-Myers Squibb, Merck and GlaxoSmithKline

Market Insights

This market growth is fueled by a growing geriatric population, changing lifestyle, increasing prevalence of chronic diseases, superior clinical results of new drugs and biologics, increasing trend of digital health, the U.S.

Patient Protection and Affordable Care Act, increasing awareness in the developed world, strong research and development (R&D) initiatives from key market players, increasing government initiatives, patient assistance programs, regulatory efforts to provide smooth regulatory approval process, adoption of portable/wearable device technologies and adoption of advanced software applications; further, keydrivers for the market include smart pills, targeted therapy, advanced needle-free drug deliverytechnologies, drug-device combinations and development of home-care and self-medication devices.

However, some of the key market barriers are lack of awareness in underdeveloped countries, poormedication adherence, patent expiry blockbuster drugs and biologics, shorter product life cycles fordevice technologies, regulatory issues (stringent regulatory approval procedure), increasing R&D cost,health disparities in in low-income countries, higher cost of the cancer treatment, data privacy, datasecurity and data accuracy.

Regionally, the U.S. is expected to maintain dominance in the therapeutics and device technologies segments of global chronic disease management market. Those wishing to invest in the chronic disease management therapeutics and device technologies market ought to strongly consider high-growth areas such as pharmaceutical drugs, biologics, medical device technologies and software applications.

Key Topics Covered

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Chronic Diseases and Growing Burden on Economy

Background of Chronic Diseases
Epidemiology and Global Burden
Chronic Diseases Types
Cardiovascular Disease
Lifestyle Disorders
Cancer
Respiratory Disorders
Musculoskeletal Disorders
Mental/Mood Disorders
Gastro-Intestinal Disorders
Immune Disorders
Neurological Disorders
Other Chronic Disorders
Tobacco Smoking and Chronic Diseases
Aging, Gender and Chronic Diseases
Global Demographics
U.S. Demographics
U.S: Gender, Age and Life Expectancy
European Demographics
Japanese Demographics
Current Challenges and Future Directions

Chapter 4 Chronic Diseases: Therapeutics

Therapeutics and Chronic Diseases
Generic Drugs and Chronic Diseases
Generic Drugs vs. Branded Drugs
Continued Resistance for Generics
Biologics and Biosimilars for Immune-Mediated Chronic Diseases
Cancer and Targeted Therapy
Clinical Need of Therapeutics
Therapeutics and Cost Burden
Chronic Diseases and Managed Care
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Unmet Need
Current Challenges and Future Developments

Chapter 5 Device Technologies and Applications

Medical Devices and Chronic Disease Management
Clinical and Market Need of Digital Therapeutics
Types of Device Technologies
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Key Marketed and R&D/Pipeline Products
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Advantages of Chronic Disease Management via Digital Care
Unmet Need
Future Developments for Healthcare and Safety Monitoring
Current Challenges
Future Outlook

Chapter 6 Chronic Diseases: Treatment Adherence Devices and Applications

Treatment Nonadherence
Market Need for Medication Adherence Systems and Applications
Types of Medication Adherence Systems and Applications
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Key Marketed and Pipeline Products
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Software and Mobile Application Advantages
Interconnectivity of Adherence App
Effectiveness of Smartphone Adherence Apps
Current Challenges
Future Developments

Chapter 7 Market Size and Growth Analysis

Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Product Segment
Market Size and Growth Analysis, by Chronic Disease Type
Market Size and Growth Analysis, by Treatment Provider and Target Health Settings
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints

Chapter 8 Competitive Landscape in the Chronic Disease Management Market

Competitive Landscape: Chronic Disease Management with New Therapeutics and Advanced Device Technologies

Chapter 9 Strategies in the Chronic Disease Management Market

Consolidation in the Chronic Disease Management Market
Mergers and Acquisitions in the Chronic Disease Management Market
Recent Mergers and Acquisitions
Device Technologies
Therapeutics (Drugs and Biologics)
Minority Stakes and Future Options to Acquire
Future Strategic Landscape

Chapter 10 Regulatory Structure: Pharmaceuticals and Medical Devices

Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union
Japan
Regulatory Systems for Pharmaceuticals, by Region
U.S.
Europe
Japan

Chapter 11 Pricing and Reimbursement: Pharmaceuticals and Medical Devices

Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Other Asia-Pacific
Pricing and Reimbursement for Pharmaceuticals, by Region
U.S.
Europe
Japan

Chapter 12 Conclusions - Outlook for Chronic Disease Management

Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Lifestyle Medicine
Patient-Centric Programs
Long-Term Outlook for Chronic Disease Management

Chapter 13 Company Profiles

3Rings
Abbott Laboratories
Abbvie Inc.
Acadia Pharmaceutical
Acorda Therapeutics
Actualmeds
Agenus
Actavis Plc
Adherium
Akron
Alivecor
Amgen Inc.
Amiko
Animas (A Subsidiary Of Johnson & Johnson)
Ani Pharmaceuticals
Aliphcom
Allergan
Alkermes
Amneal Pharmaceuticals
Anavex Life Sciences
Apotex
Archos
Arena Pharmaceuticals
Array Biopharma
Aslan Pharmaceuticals
Asahi Kasai Corp.
Aspen Pharmacare
Astrazaneca Plc
Astellas Pharma Inc.
Athersys
Audentes Therapeutics
Axiobionics
Axsome Therapeutics
Ayogo Health
Bausch Health
Bayer Ag
Bespak Europe
Beigene
Bioxcel Therapeutics
Biosensics
Bioserenity
Biotronik Gmbh
Biotricity
Biovotion
Bodytel
Boehringer Ingelheim
Boston Scientific
Bristol-Myers Squibb
Brainmarc
Bts Bioengineering
Cardiomems Inc. (A Subsidiary Of St. Jude)
Celgene
Chugai Pharmaceuticals Co., Ltd.
Cipla
Cleveland Medical Device
Clovis Oncology
Connectedhealth Pte. Ltd.
Corbus Pharmaceuticals
Cspc Pharmaceutical Group
Daiichi Sankyo
Dexcom Inc.
Depomed Inc.
Dr. Reddy's Laboratories Ltd.
Earlysense
Edwards Lifesciences Corp.
Eisai
Eli Lilly
Empatica
Endo International
Endotronix
Entra Health Systems
Endoceutics Inc.
Erytech Pharma
Esteve
Everist Health
Five Prime Therapeutics
Glaxosmithkline Plc
Glooko, Inc.
Gilead Sciences
Glucovista Inc.
Goodlux Technology Llc
Halozyme Therapeutics
Health Care Originals
Hikma Pharmaceuticals
Hocoma
Ihealth
Immunomedics
Impact Sports Technologies
Impak Health
Infobionic Inc.
Insulet Corp.
Intelesens
Intra-Cellular Therapies
Iovance Biotherapeutics
Ipsen S.A.
Jan Medical Inc.
Jiangsu Hengrui Medicine
Johnson & Johnson
Lundbeck
Lupin
Kyowa Hakko Kirin
Les Laboratoires Servier
Livanova Plc
Mallinckrodt Plc
Medtronic
Medtronic Minimed Inc. (A Subsidiary Of Medtronic)
Medconnections Inc.
Medminder
Menarini
Merck
Mio Global
Mitsubishi Tanabe Pharma
Mylan Inc.
Mycardio Llc
Nemaura Medical Inc.
Neofect Co., Ltd.
Neurocrine Biosciences
Neurometrix Inc.
Neurovigil Inc.
Novartis
Novo Nordisk
Novasom Inc.
Nucana
Omada Health Inc.
Omron Corp.
Omnicell Inc.
Ono Pharmaceutical Co., Ltd.
Orion Pharma Ltd.
Orpyx Medical Technologies
Otsuka Pharmaceuticals
Pacira Pharmaceuticals Inc.
Pfizer
Philosys
Polar Electro Oy
Preventice Inc.
Prescribewellness Llc
Prizm Medical Inc.
Propeller Health
Proteus Digital Health Inc.
Proteostasis Therapeutics
Qardio
Rehab-Robotics (A Member Of Vincent Medical Holdings)
Rexahn Pharmaceuticals
Roche
Sage Therapeutics
Sanofi
Sarepta Therapeutics
Sense4Care
Senseonics Holdings
Senticare Inc.
Shanghai Pharmaceuticals Holding
Shionogi And Co., Ltd.
Silvergens
Sproutling Inc. (Acquired By Manttel)
St. Jude Medical (A Subsidiary Of Abbott Laboratories)
Stada Arzneimittel Ag
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharmaceutical Industries
Takeda Pharmaceutical Co., Ltd.
Taisho Pharmaceutical
Tcr2 Therapeutics
Teva Pharmaceutical Industries
Towerview Health, Inc.
Translate Bio
Tyme Technologies
UCB
Unilife Corp.
Vertex Pharmaceutical
Vaica
Vital Connect
West Pharmaceutical Services Inc.
Winmedical Srl
Ybrain
Ypsomed Holding Ag
Zogenix Inc.
Zydus Cadila

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

For more information about this report visit https://www.researchandmarkets.com/r/j1nikl

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets